Cross-disease transcriptomic meta-analysis and network pharmacology reveal key therapeutic targets in rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis

These findings explored identifying the DEGs among shade of the autoimmune disease RA, SLE, MS, and this hub gene are associated with transcription factors are most crucial role play in the disease potentially clinical therapeutic targets of the autoimmune disease.